The third generation EGFR TKI targets EGFR mutant NSCLC, showing improved progression free survival and fewer adverse events ...

Scotland’s NHS can now offer givinostat to ambulant children with Duchenne muscular dystrophy, marking a step forward in care ...

Patients with high volumes of fat tissue around the heart may experience greater myocardial injury after acute myocardial ...

Lower urinary tract symptoms are not associated with an increased risk for high-grade prostate cancer, rendering biopsies and ...

Respiratory syncytial virus infection in adults aged 45 years or older is significantly associated with a higher 1-year risk ...

Use of the antifibrinolytic medication ‘narrowly exceeded’ noninferiority in VTE risk compared with placebo in noncardiac ...

The European regulator has recommended marketing approval for Ranluspec and Gotenfia after studies confirm their safety, ...

The treatment combination was previously approved in BRCA2m-positive patients with metastatic castrate-resistant prostate cancer.

The growing evidence that inflammation is a primary cause of aging skin supports ongoing efforts to study targeted ...

Europe’s 2040 tobacco-free goal faces hurdles from new products and funding gaps. Success depends on integrating cessation ...

Kim Allan Williams, MD, discusses how the ACC’s endorsement of front-of-package nutrition labeling may change the ...

So far, “the only established risk factors for prostate cancer are advancing age, African ancestry, and a family history of ...